ELI LILLY & Company ,   USA

Antitumour agent, antimetabolite
Lyophilizate for the preparation of a solution for infusions of 100 mg in a vial.
Antitumour agent, antimetabolite
Lyophilizate for the preparation of a solution for infusions of 200 mg or 1 g.
antipsychotic agent (antipsychotic)

Powder for suspension for intramuscular injection 210 mg, 300 mg or 405 mg complete with a solvent.

antidepressant
Capsules intestinal soluble 30 mg or 60 mg.
hypoglycemic agent - a glucagon-like receptor polypeptide agonist

A solution for subcutaneous administration, 0.75 mg / 0.5 ml or 1.5 mg / 0.5 ml.

hypoglycemic agent - short-acting insulin analog
Solution for intravenous and subcutaneous administration, 100 IU / ml.
Hypoglycemic agent is a combination of insulin analogues of short and medium duration of action

Suspension for subcutaneous administration, 100 IU / ml.

Hypoglycemic agent is a combination of insulin analogues of short and medium duration of action
Suspension for subcutaneous administration, 100 IU / ml.
hypoglycemic agent - a combination of insulin of short and medium duration of action

Suspension for subcutaneous administration, 100 IU / ml.

hypoglycemic agent - short-acting insulin

Solution for injection, 100 IU / ml.

Antineoplastic agents, monoclonal antibodies

Concentrate for the preparation of a solution for infusions of 10 mg / ml.

antiplatelet agent

Tablets, film-coated, 5 mg and 10 mg.